Skincare brand Be Clinical raises ₹21 cr in seed funding
The company plans to utilise the fresh capital to strengthen its research and development capabilities, expand the clinical skincare range
Skincare brand Be Clinical has secured ₹21 crore in seed funding, according to a statement released on Monday. The investment, led by venture capital firm Sauce, aims to bolster product innovation and broaden its clinical skincare offerings. Additional participants in the fundraising round included V3 Ventures (Verlinvest SA) and a coalition of angel investors, namely Mokobara founders Sangeet Agrawal and Navin Parwal, Reckitt's SVP & Managing Director for Greater China & North Asia Arjun Purkayastha, and Be Clinical employee Shaunak Chirayu Amin.
With the fresh capital, Be Clinical plans to enhance its research and development (R&D) capabilities, broaden its clinical skincare line-up, expand manufacturing capacity, and venture into new markets and regions. For Hemangi Dhir, founder of Be Clinical, the ₹21 crore is not merely about the financial influx, but rather the trust and responsibility that comes with it.
She believes the funds will empower the company to further invest in R&D, fortify its manufacturing and clinical capabilities, build a more robust team, and reach a larger consumer base across India.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
